Barcelona 2015 Programme Registration Glaucoma Day 2015 Exhibition Virtual Exhibition Satellite Meetings Hotel Booking Star Alliance

Take a look inside the London 2014 Congress


Then register to join us
in Barcelona!


Search Abstracts by author or title
(results will display both Free Papers & Poster)

Clinical outcomes of Tetraflex accommodative intraocular lens implantation 2 years after surgery

Poster Details

First Author: H.Tarakcioglu TURKEY

Co Author(s):    U. Yigit   I. Onur   A. Agachan              

Abstract Details


To evaluate distance–near visual performance and measure subjective and objective accommodative amplitude of eyes 2 years after surgery, in which Tetraflex accommodating intraocular lens (IOL) was implanted.


Eye Clinic, Bakirkoy Dr. Sadi Konuk Hospital, Istanbul, Turkey


Tetraflex IOL implanted 16 eyes of 14 cataract patients were evaluated at 2 years after surgery. Uncorrected (UCVA) and best corrected distance visual acuities (BCVA), uncorrected (UNVA), distance-corrected near visual acuities (DCNVA), best corrected near visual acuities (BCNVA) and spherical equivalent (SE) refraction were measured respectively. Subjective defocusing and objective anterior chamber depth (ACD) assessment before and after topical application of pilocarpine using Scheimpflug topographer combined with Placido disk were the concomitant methods for measuring accommodative amplitude.


No postoperative complications were observed. Measurements at 2 years follow-up visit: UCVA, BCVA, UNVA, DCNVA and BCNVA were 0.13 ± 0.16; 0.00 ± 0.05; 0.52 ± 0.15; 0.61 ± 0.08 and 0.06 ± 0.07 logMAR respectively. The mean SE was – 0.29 ± 0.67 Diopters (D). The mean subjective accommodation was 1.13 ± 0.26 D (range from 0.75 to 1.50 D), whereas the mean pilocarpine-induced anterior chamber depth reduction (∆ ACD) was 0.35 ± 0.15 mm (range from 0.19 to 0.75 mm). 4 eyes (25 %) did have Nd:YAG laser capsulotomy for posterior capsule opacification by 2 years after surgery.


Tetraflex accommodative IOL keeps providing satisfactory near and distance vision performance 2 years after surgery.

Financial Disclosure:


Back to Poster listing